BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 21351256)

  • 1. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
    Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
    PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34c plays a role of tumor suppressor in HEC‑1-B cells by targeting E2F3 protein.
    Li F; Chen H; Huang Y; Zhang Q; Xue J; Liu Z; Zheng F
    Oncol Rep; 2015 Jun; 33(6):3069-74. PubMed ID: 25846116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
    Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
    FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
    Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
    Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
    Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.
    Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N
    Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
    Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
    Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
    Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
    Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.